中文 | English
Return
Total: 1 , 1/1
Show Home Prev Next End page: GO
Author:(Nathan MORRIS)

1.Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies

Taku KOBAYASHI ; Katsuyoshi MATSUOKA ; Mamoru WATANABE ; Tadakazu HISAMATSU ; Fumihito HIRAI ; Joe MILATA ; Xingyuan LI ; Nathan MORRIS ; Vipin ARORA ; Tomoko ISHIZUKA ; Koji MATSUO ; Yoichi SATOI ; Catherine MILCH ; Toshifumi HIBI

Intestinal Research 2024;22(2):172-185

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1 , 1/1 Show Home Prev Next End page: GO